Pancreatic enzyme replacement therapy for prevention of postpancreatectomy hepatic steatosis after pancreatoduodenectomy: a post hoc analysis of a randomized placebo-controlled trial
HPB · 2026-07 · 28 (7) · 869-876
DOI: 10.1016/j.hpb.2026.03.008 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HPB, 2026-07. Verfasst von Moonhwan Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Enzyme Replacement Therapy, Fatty Liver, Pancreaticoduodenectomy, Pancrelipase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Korea Health Industry Development Institute.
Abstract (Originalsprache)
BACKGROUND: Postpancreatectomy hepatic steatosis (PHS) is a long-term complication after pancreaticoduodenectomy (PD). We investigated the association between PERT and the development of PHS. METHODS: Among patients randomized to PERT or placebo after PD in a previous prospective study (NCT02127021), 94 patients with preoperative and 1-year postoperative unenhanced computed tomography (CT) were included. PHS was defined as liver attenuation of 5% at 3 months postoperatively (OR 1.602, p = 0.046). Subgroup analysis confirmed that PERT consistently reduced the incidence of PHS in patient with body weight loss of >5% after 3 months of medication administration. CONCLUSIONS: PERT was associated with a significantly lower incidence of PHS after PD than placebo, with sustained benefits in patients with significant postoperative body weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: yoonys@snubh.org.
- Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Surgery, Samsung Medical Center, School of Medicine, Sungkyunkwan University, South Korea.
- Department of Surgery, Yonsei University College of Medicine, South Korea.
- Department of Surgery, Chung-Ang University Hospital, Seoul, South Korea.
Förderung
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
Zitieren
APA
Kim, M., Yoon, Y. S., Jang, J. Y., Kwon, W., Kim, H., Yoon, D. S., Park, J. S., Lee, S. E., Lee, J. S., & Han, H. S. (2026). Pancreatic enzyme replacement therapy for prevention of postpancreatectomy hepatic steatosis after pancreatoduodenectomy: a post hoc analysis of a randomized placebo-controlled trial. HPB, 28(7), 869-876. https://doi.org/10.1016/j.hpb.2026.03.008
Vancouver
Kim M, Yoon YS, Jang JY, Kwon W, Kim H, Yoon DS, et al. Pancreatic enzyme replacement therapy for prevention of postpancreatectomy hepatic steatosis after pancreatoduodenectomy: a post hoc analysis of a randomized placebo-controlled trial. HPB. 2026;28(7):869-876. doi:10.1016/j.hpb.2026.03.008
BibTeX
@article{Kim2026,
author = {Kim, Moonhwan and Yoon, Yoo-Seok and Jang, Jin-Young and Kwon, Wooil and Kim, Hongbeom and Yoon, Dong-Sup and Park, Joon S and Lee, Seung E and Lee, Jun S and Han, Ho-Seong},
title = {Pancreatic enzyme replacement therapy for prevention of postpancreatectomy hepatic steatosis after pancreatoduodenectomy: a post hoc analysis of a randomized placebo-controlled trial},
journal = {HPB},
year = {2026},
volume = {28},
number = {7},
pages = {869--876},
doi = {10.1016/j.hpb.2026.03.008}
}
EUVIMED